Introduction Vaccine pharmacovigilance is an essential component of vaccine safety
programs. Vaccine pharmacovigilance refers to detecting uncommon adverse events …

Abstract In May 2023, the Food and Drug Administration (FDA) licensed Arexvy and Abrysvo
vaccines for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in …

Background and purpose The association between Guillain− Barré syndrome (GBS) and
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is debated. This study …

Summary The EAN/PNS GBS and CIDP criteria detail specific clinical, electrophysiological,
and laboratory features that raise diagnostic confidence, and call attention to diagnostic …

Despite the fact that the global COVID-19 pandemic has officially ended, we continue to feel
its effects and discover new correlations between SARS-CoV-2 infection and changes in the …

Background and purpose Various electrodiagnostic criteria have been developed in Guillain–
Barré syndrome (GBS). Their performance in a broad representation of GBS patients has not …

Background and purpose Since its description by Guillain, Barré, and Strohl in 1916,
Guillain–Barré syndrome (GBS) has attracted a large literature. The author reviews the …

The bachelors thesis examines with the issue of Guillain-Barré syndrome. The theoretical
part of the thesis describes the definition of Guillain-Barré syndrome, epidemiology, and …

Electrodiagnostic studies (EDx) are frequently performed in the diagnostic evaluation of
peripheral nerve disorders. There is increasing interest in the use of newer, alternative …

Background & purpose In this retrospective study, we aimed at defining the clinical,
paraclinical and outcome features of acute neurological syndromes associated with anti …